When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ARDS - Aridis's AR-501 shows positive effect in early-stage study
Aridis Pharmaceuticals Inc.
Aridis Pharmaceuticals's (ARDS-3.0%) AR-501 aerosols demonstrated to be well tolerated, with no serious adverse events, in phase 1 portion of Phase1/2a trial.
More news on: Aridis Pharmaceuticals, Inc., Healthcare stocks news,